Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 14, 2019; 25(38): 5732-5772
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5732
Published online Oct 14, 2019. doi: 10.3748/wjg.v25.i38.5732
Gene name | Cancer | Role | Functional activity |
ZnT1/SLC30A1 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZnT2/SLC30A2 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZnT3/SLC30A3 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZnT4/SLC30A4 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZnT5/SLC30A5 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
ZnT6/SLC30A6 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
ZnT7/SLC30A7 | Esophageal colorectal | Oncogene oncogene | Increased mRNA expression in tumors[308,335] Increased mRNA expression in tumors[337] |
ZnT8/SLC30A8 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZnT9/SLC30A9 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
ZIP1/SLC39A1 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
Pancreatic | Tumor suppressor | Down regulated mRNA expression in tumors[313] | |
ZIP2/SLC39A2 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
Pancreatic | Tumor suppressor | mRNA expression down-regulated in tumors[313] | |
ZIP3/SLC39A3 | Pancreatic | Tumor suppressor | Decreased expression in adenocarcinoma[308,313,331,343] |
Oncogene | Medium to high mRNA expression in multiple human PC cell lines[313] | ||
ZIP4/SLC39A4 | Hepatocellular | Oncogene | Increased mRNA and protein expression, repressed apoptosis, enhanced cell cycle and migration[308,325,344-346] |
Pancreatic | Oncogene | Increased expression in PDAC and PC cell lines, link to CREB-miR-373 axis, promotes cancer xenograft growth in nude mice[313,325-327] | |
Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
ZIP5/SLC39A5 | Esophageal | Oncogene | Increased expression in ESCC, knockdown in cell lines inhibited migration and invasion[308,334] |
Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
ZIP6/LIV-1/SLC39A6 | Pancreatic | Oncogene | Increased expression in tumors and cell lines[313,330] |
Tumor suppressor | Decreased mRNA expression in tumors[313] | ||
Hepatocellular | Oncogene | Increased mRNA and protein expression[308,347] | |
Esophageal | Oncogene | Increased expression in ESCC[308,333] | |
Colorectal | Oncogene | Increased mRNA expression in tumors[337] | |
Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
ZIP7/SLC39A7 | Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
Colorectal | Oncogene | Increased mRNA expression in tumors and CRC cell lines, knockdown inhibits cell growth and induces apoptosis in cell lines[339] | |
Gastric | Undetermined | Increased mRNA expression, but better patient prognosis[338] | |
ZIP8/SLC39A8 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
ZIP9/SLC39A9 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] | |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
ZIP10/SLC39A10 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
ZIP11/SLC39A11 | Colorectal | Oncogene | Increased mRNA expression in tumors[337] |
Gastric | Undetermined | Increased mRNA expression in tumors, better patient prognosis[338] | |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
ZIP12/SLC39A12 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
ZIP13/SLC39A13 | Gastric | Oncogene | Increased mRNA expression in tumors, worse patient prognosis[338] |
Pancreatic | Tumor suppressor | Decreased mRNA expression in tumors[313] | |
Oncogene | Medium to high mRNA expression in multiple human cell lines[313] | ||
ZIP14/SLC39A14 | Hepatocellular | Tumor suppressor | Decreased expression in hepatoma tissues[308,348] |
Gastric | Undetermined | Increased mRNA expression in tumors, but better patient prognosis[338] | |
Tumor suppressor | Decreased mRNA expression in tumors[313] | ||
Pancreatic | Oncogene | Medium to high mRNA expression in multiple human cell lines[313] |
- Citation: Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol 2019; 25(38): 5732-5772
- URL: https://www.wjgnet.com/1007-9327/full/v25/i38/5732.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i38.5732